Nonsteroidal Antiinflammatory Drugs for Acute and Chronic Pain

被引:33
|
作者
Atkinson, Timothy J. [1 ]
Fudin, Jeffrey [2 ,3 ,4 ]
机构
[1] VA Tennessee Valley Healthcare Syst, PGY2 Pain Management & Palliat Care Pharm Residen, Pain Management, 3400 Lebanon Pike, Murfreesboro, TN 37129 USA
[2] Albany Stratton VA Med Ctr, PGY2 Pain Management & Palliat Care Pharm Residen, Pain Management, 113 Holland Ave, Albany, NY 12208 USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] Remitigate LLC, Delmar, NY USA
关键词
NSAIDs; Chronic pain; Stiffness; Inflammation; Adjuvant analgesics; Nonopioid; GASTROINTESTINAL TOXICITY; MYOCARDIAL-INFARCTION; REGIONAL-ANESTHESIA; AMERICAN-SOCIETY; RISK; CYCLOOXYGENASE-2; KIDNEY; NSAIDS; RECOMMENDATIONS; OSTEOARTHRITIS;
D O I
10.1016/j.pmr.2020.01.002
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Understanding nonsteroidal antiinflammatory drug (NSAID) use and impact on common rheumatic and arthritic conditions is critical to reconciling their appropriate use with their potentially serious adverse effects. NSAIDs have a profound impact on the treatment of connective tissue disorders because of their ability to address the underlying cause with specific benefits of decreasing stiffness and inflammation, and improving mobility. NSAID use is twice as common as opioid use, and inappropriate use of NSAIDs is widespread. NSAID use should be monitored and the impact understood to mitigate the risks. NSAID discontinuation should be evidence based and individualized to specific requirements.
引用
收藏
页码:219 / +
页数:14
相关论文
共 50 条